Legislation

Title: Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products
Sponsored by: Senator Gile
Status: In the Senate - Withdrawn by Sponsor
Analysis: Fiscal and Policy Note

Synopsis

Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid overdose without imposing a copayment or coinsurance requirement that exceeds $10 per package.

Committees

Original:: Finance

Details

Cross-filed with: HB0736

Bill File Type: Regular

Effective Date(s): January 1, 2025

History

Legislation History
Chamber Senate Calendar Date 1/24/2024 Legislative Date 1/24/2024 Action First Reading Finance Proceedings
Chamber Senate Calendar Date 1/24/2024 Legislative Date 1/24/2024 Action Hearing 2/07 at 2:00 p.m. Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products Proceedings
Chamber Senate Calendar Date 2/05/2024 Legislative Date 2/05/2024 Action Hearing canceled Proceedings
Chamber Calendar Date Legislative Date Action Vote - Senate - Committee - Finance Proceedings Click to view Recorded Media
Chamber Senate Calendar Date 3/04/2024 Legislative Date 3/04/2024 Action Withdrawn by Sponsor Proceedings

Chamber	Calendar Date	Legislative Date	Action	Proceedings
Senate	1/24/2024	1/24/2024	First Reading Finance
Senate	1/24/2024	1/24/2024	Hearing 2/07 at 2:00 p.m.
			Text - First - Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products
Senate	2/05/2024	2/05/2024	Hearing canceled
			Vote - Senate - Committee - Finance	Click to view Recorded Media
Senate	3/04/2024	3/04/2024	Withdrawn by Sponsor

File Code

Subjects

Statutes